A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer
Clinical trial NCT04718740 · COMPLETED
Trial details
- NCT number
- NCT04718740
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2022-10-26
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.